Company Filing History:
Years Active: 2004-2006
Title: Innovations of James Alan Bonner
Introduction
James Alan Bonner is a notable inventor based in Vestavia Hills, Alabama. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents.
Latest Patents
Bonner holds two patents related to human anti-epidermal growth factor receptor single-chain antibodies. These antibodies were isolated from a human IgM phage display library using purified epidermal growth factor receptor as an antigen. Two isolates with different amino acid sequences were identified by ELISA as epidermal growth factor receptor-specific. The single-chain variable fragments (scFvs) bind to the full-length epidermal growth factor receptor and the truncated and/or mutated epidermal growth factor receptor on human cells. These anti-EGFR-scFvs are useful as therapeutic and/or diagnostic agents.
Career Highlights
Bonner is associated with the UAB Research Foundation, where he continues to advance his research and innovations. His work has implications for cancer treatment and diagnostics, showcasing his commitment to improving healthcare outcomes.
Collaborations
He has collaborated with notable colleagues, including Kevin Paul Raisch and David T. Curiel, contributing to a dynamic research environment.
Conclusion
James Alan Bonner's work in the field of anti-epidermal growth factor receptor antibodies exemplifies the impact of innovative research on medical science. His contributions are paving the way for future advancements in therapeutic and diagnostic applications.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.